pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-203b |
Genomic Coordinates | chr14: 104117418 - 104117503 |
Description | Homo sapiens miR-203b stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-203b-3p | |||||||||||||||
Sequence | 54| UUGAACUGUUAAGAACCACUGGA |76 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PAPOLG | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | poly(A) polymerase gamma | ||||||||||||||||||||
Transcript | NM_022894 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PAPOLG | |||||||||||||||||||||
3'UTR of PAPOLG (miRNA target sites are highlighted) |
>PAPOLG|NM_022894|3'UTR 1 AAGCAGTGCCTCCTCACTTAAGTGAACAAGCAATCATTTAGTGGCATAGATGCAGCCACTTGTTTTTTAAATAGAAGTGG 81 CTGTCATACGTGAAATAAGGTGAAAGTGACAGCCTTCAGTCTAATAACCTTGAAGTGGTTTTTGAACTGTCAAACTTTGA 161 CCTGTAGATGCTGTAGCATTCTCTCACTGATTGCTACATACACTTCTCTGAGGATCACCTGCTGTCAAATTGCCATCTAC 241 AGTATTACAGCTTTGCATTTGGGGGTTTTACTGCCTTAACTTTCAATGCTTGTTATGGGAACCAGTTCTTAGCCACTTGG 321 ACACTGATAACAAGTCCTGAACTCCTTTTTTGTTTTGTTTTTTGTGTTTTTCTTTTTTTGTCTTATGTTGTAATCATTGT 401 ATAGAGCTAAAAAAATTGAAAACAAACAAAAAAATTGTCTTGTATTTTCCAAATGTTAATACATTTACTTTAGCATTGAA 481 GCCACTTTGAAACCTGAGATAAATGAATGTGAGGTATCTTTTCTGCTTTCCTCATTTGTGTAGATGTACTGTCTGTTCTG 561 TTGATTTAAATTATTTTTTTCCAGATTGGCACATGAAATATTTAAACTTTTTTGTGTGCCTTTCTGTCCAAATGTTGCAT 641 AGTTACCAGGGAAGATTAGTCCAGTGATTACATAAGAGTTGGGCACCATAAATTCTCTATATTTTGCCTCCCATGGAGGC 721 CTTTGAAATGCATCTTTATTAAAAATCAAAATATAACCAGGATACTGAAAGTCAGTATATGAATGGTAAAATTGTTACAT 801 ATCCTATTTCATGCCATTCTTGTTAGTTGACTGGTATTTTTTACTGAGGAGCAACTCATTCCAGCATCAACAATAAGATA 881 ACCTTTAAGTATGGCACACTTGTATTTTTGAGGTGTAAAATTAACTTGGCATGATAATTCCTGATCATTATTTACCCCAC 961 AACTTCAAATAGTTTCTTCACGGACTAGGCATGCAGAAATAAGCAGTGGATTTTATTGAAACCTAAAGGCATTTTGAATG 1041 ACATTGTTACCAACCATTAATTGGCTCAGGACCTTTGTAATTTTTATTTAACTATATGAGTTGTCTTTTTTTACGCTGCT 1121 TTTTTCAATGCATTTCTTAATATTTTTTAAGTTTCATGAATGCATGCTCAGTTTATTAAAATCCATAACCATGTAATTCT 1201 TGTAATATGTTGATTCAGTGTTTTGTAAATGAAGTCGTATGTATTTTCAGAGTATTTTTGTATGTACTGTAAGATACCAT 1281 CTTTTCAAAGAGAAACGTTTAAAACCTTTATTGTCTCTCCTTAGTCTAATTTTTTAAATATGGATTATGCTTGAATTACT 1361 ATATTTAAAATGAAAATGTATAGATTACACAGCCAGGAATGCTAGTATCTACCACCTTCTTTAGATTTCACTCAGCATTT 1441 AGTAGGTCCAGTAGGAAAAACCCAAAATGGTACATTGAGTAGTGTGGGGAAGACACCTCGTGTATTATAGGACTCACGGG 1521 ATGCCATCTAGCAAGTGGAGAAATAGCAGTCCATTTTCTCTTGCAAGCCCTTTACCATTGAGTTGAAATTCTTGAATTGC 1601 CAGAGAGCCGTATCCTCCAGGTCCCACTCCTGTTCATTGCCCCTTAGGTCTCCAAAATGTAAATTCTAATGTTTACCTTG 1681 TACCATGGAAAACATGAAAAGAGTCTTAGAAGTAAAGAACAACAAGGAAAAAAATGTTTGTTCTATTATTCCCTTTTTAT 1761 ATAGCAGCAAAAGATAAGAATAAAATCACATAACCAAGTTGAAGCTTCCTTGGCAAAGCTGTTGTCTTAGCTGACTCTTT 1841 CCCTTTATTCAGATGTTTTGGGATTGTTCTACAAATAGTCTATTTGAGCAAAAATGAATGATTATGAAAGAACCGAAGAA 1921 TTATCACCTGACTTCAACTTTTGAAAGCTTTAGTAAGGAATTTGATTAAATTTTATATACTGGATGTGTATGCATTTCTG 2001 CATTTCATATCTTTTGCTTTTAAATCAGCCTTCAAAGTATCTTTAGGAATTCCTTCTGTATCCATGTTTACCCCATTATG 2081 TAAATAGATCTTTGGAGTGACTAGTGGAGTTTTTCTTTAATAAGGAAGCAACAAGTCTAACCTTGTACTATAGGATAGGC 2161 ATTTATTTTAGATTAAGGAGCCCATTCAACATGTCAATGAGTCAACATTAGAGTCCTCAAAGATAGCATTCTTCAACCTG 2241 TTTGGTAACTGAGGAGTTGATAAAATACTTTTGAGATGGTGGGGTTTGTCAGAAATAAAATATTTTCTATCCTGACCAGT 2321 AGGTAGAACTTTGAGTACATTTCGTTAACTTGGTGGGAAGCTTCCATTGTACTAGTTCCAAGTAAAAAAGGAGAAAGTAT 2401 GATCTGGGATTTTGTGTTATGATGAGAGGCACTAAGTACATGTGTTTGTTTTGTTTTGTTTTGTTTTGTTTTGTTTTGTT 2481 TGAGACAGAGTTTTGCTCTTGTTGCCCAGGCTGGAGTGCAGTAGCCCAATCTCGGCTCACTGCAACCTTCACCTCCCGAG 2561 TTCAAGCTATTCTCTTGCCTCAGCCTCCCAAGTAGCTGGGATTACAGGCACCCACCACCTCGCCCAGCTAATTTTTGTAT 2641 TTTTAGTACAGACAGCGTTTCACCATGTTGGCCAGGCTGGTCTCGAACTTGTGACCTCAGGTGATCCACCTGCCTCGGCG 2721 TCCCAAAGTGCTGGGATTACAGGCGTGAACCACCGCACCCGGCCGTGTTTGTTTTCAAGTGTGAAAAAATACCTAGAAGT 2801 ATATTTTATGAAGTCAAATAATCTGTTCTTCAGTATATAGACACATGTTCATTTTCACAAGGGCATTACATTTTAATTTG 2881 CTCATTTTTCAGTAGCTCTGGAGAATATGTATGAAAGGAAAACAATTACCTGCTAGCTTAAACCTTAGGGACTTAACCAA 2961 TTCAAGATAGAGGTACATGGCTTAAAACTTTGTAAAACTGGGACAGGAGAATTATTATTTTTTTATTTTTTATTTTTTTA 3041 TGAAGACAAGAGTTTCACTCTGTCACCCAGTCTGGAGCACAGTGGCATGATCTCACCTCACTGCAACCTCTGCCTCCCGG 3121 GTTCAAGTGATTCTCTTGCCTCAGCCTCCCAAGTAGCTGGAATTACAGGCCTGTGCCATGCCCAGCTAATTTTCGTATTT 3201 TCAGTAGAAATGGGATTTCACCATGTTGGCCAGGGTGGTCTTGAACTCCTCACCTCAAGTGATCTGGCTGCTTCGGCCAC 3281 CCTAAGTGCTGGGATTACAGGCATAAGCTACTGTGCCCAGCCAGGAGAATGAATTTTAAAAATCTATGTTAGTGTTTAAA 3361 ATGAGTGCTTTGTTTTAAAGCAGCAATTTAGTAGCATTATTAAAATGCTTACTTCACTATAGTAGCAATTAGGTAAAGAT 3441 GGGCAATATCAAAATGGGCTAAACTTATTTTCCACTATGTTCCACACCTTTGAAATAGGAATTCCTAACTTGAGAATCAT 3521 GAACCCTTAGGGAATCCTTTATAATTGTGTATAAGAAGTTCTAGTTTACATGCATTTTTCTTGGGGAAAGTGCATAGTTT 3601 AGATCAGCTTCTCGAAGTGGCAAAAGTATGGGAGTTAGGGTTAGGAACCACCAGGATTGAATAATCCTGGAATATTATAT 3681 AATTTTCTACTTTTGATTTTGCTGTGGTATATTTCTGAAAATGTGCTGTGGCTCCTAACTAGTAAAATGGGCTGGTGAGG 3761 GACTCTGGAATTCTGAATTTCTAAGTTTATAACCTAAAATGAAACTGTAAAGTCCTCGGTATTTAGAAAAATGCTTAATC 3841 TCAGATTTACAGATGGCCTCATGATAACTTAGATTCGTTAACAGGGTCAAACTTTAGTTCAACAAATTTCAACCCAATAT 3921 TATCACAGTACAATAGCTTAGAATGATCATTAGAAATGGTAGAAAATAGAATAAATCATTAAAGATCCCAAAATGTTGAG 4001 TTCTGTAGCATGAAAACTCTCTTGCTCCTCCATGTTTGTAGTTCAGGCCAGAACAAACTAAACAGACCAATAAATATAAA 4081 AGTGATAGTTTAGGGAAAAAAAAAAACTTTGTATAAATAAAATTGTATGTGTGTTCAAATAACTACCTATTAAATCATCC 4161 AAAGCTTAGAATTTAAATTGGTCATAGTAGCAAATAGTGCAGATGATGGAAGAAAACCAGTCTCAATAATGGTTTTTTTT 4241 TTCCAATTGCATAAGGTCACGTCATCCCCCAAATTGTCTATTTTTTCTTTTCTTTTTTTTTAAGATGGAGTCTCGCTCCG 4321 TCACCCAGGCTGGAATGCAGTGGCGCAATCTTGGCTCATTGCAACCTCCACCTCCCAGGTGCAAGCGATTCTCCTACCTC 4401 AGCCTCCCAAGTAGCTGGGACTACAGGCGCCCGCCACCATGTGGGCCTGGCTAATTTTTGTAGAGATGGGGTTTCAACAT 4481 GTTGGCCAGGCTGGTCTCAAACTCCTGACCTCCAGTGATGCACCCGCCTCGGCCTCCCAAAGTTCTGGGATTACAGGCGT 4561 GAGCCACCGTGCCCAGCCCCTATTTTTTCTGAAATAATTTTTCGGATATACTTTTATATTTGAAATTAGTTGAACATAAG 4641 ATGATCATCAAGCTTGCTATAAGTTTTAAGCTATTGCTACATTTGAACAAAGACCCACGTACTTATCTTAGAAAGTACTT 4721 AGGATATCTTTGAGATTAATGGTGCTACATCACTCTACAGTACTATGTAAAATGAATGGAGCTGCTGTTCCTTTCTAGCT 4801 AGCTGTTTGTGTAGTTCATATTAATTTACCCTGCCTTTTATTTGGATTGTCTGATTTCTTAGTTGTACACATGAACCTCA 4881 TTATTTGCCTGGAATAAGTAATCAAATAAAATTGCTTTGATAAATA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | BC-1 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796037. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796037 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000238714.3 | 3UTR | UCAAGCUAUUCUCUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
154 hsa-miR-203b-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT063500 | SKI | SKI proto-oncogene | 2 | 4 | ||||||||
MIRT149737 | LDLR | low density lipoprotein receptor | 2 | 6 | ||||||||
MIRT206557 | SOCS5 | suppressor of cytokine signaling 5 | 2 | 8 | ||||||||
MIRT248820 | SESN2 | sestrin 2 | 2 | 2 | ||||||||
MIRT261314 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 2 | ||||||||
MIRT443290 | TAF8 | TATA-box binding protein associated factor 8 | 2 | 4 | ||||||||
MIRT443893 | NUDT3 | nudix hydrolase 3 | 2 | 4 | ||||||||
MIRT444057 | SERPINA4 | serpin family A member 4 | 2 | 2 | ||||||||
MIRT444345 | KIAA1211 | KIAA1211 | 2 | 2 | ||||||||
MIRT444538 | AGAP9 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 | 2 | 2 | ||||||||
MIRT444594 | TGFA | transforming growth factor alpha | 2 | 2 | ||||||||
MIRT445601 | SEC14L3 | SEC14 like lipid binding 3 | 2 | 2 | ||||||||
MIRT446025 | PNKD | paroxysmal nonkinesigenic dyskinesia | 2 | 2 | ||||||||
MIRT446309 | TBC1D8B | TBC1 domain family member 8B | 2 | 2 | ||||||||
MIRT446492 | TMEM215 | transmembrane protein 215 | 2 | 4 | ||||||||
MIRT446728 | SLC36A4 | solute carrier family 36 member 4 | 2 | 2 | ||||||||
MIRT447468 | CISD2 | CDGSH iron sulfur domain 2 | 2 | 2 | ||||||||
MIRT447504 | MRPS5 | mitochondrial ribosomal protein S5 | 2 | 2 | ||||||||
MIRT447597 | MRPL3 | mitochondrial ribosomal protein L3 | 2 | 2 | ||||||||
MIRT447636 | AGPS | alkylglycerone phosphate synthase | 2 | 2 | ||||||||
MIRT447846 | ZRANB2 | zinc finger RANBP2-type containing 2 | 2 | 2 | ||||||||
MIRT448098 | TCN2 | transcobalamin 2 | 2 | 2 | ||||||||
MIRT448111 | SEMA4G | semaphorin 4G | 2 | 2 | ||||||||
MIRT448903 | CLCN6 | chloride voltage-gated channel 6 | 2 | 4 | ||||||||
MIRT449396 | TOX4 | TOX high mobility group box family member 4 | 2 | 2 | ||||||||
MIRT449484 | CACNA2D4 | calcium voltage-gated channel auxiliary subunit alpha2delta 4 | 2 | 2 | ||||||||
MIRT450705 | RNF152 | ring finger protein 152 | 2 | 2 | ||||||||
MIRT450781 | PAPOLG | poly(A) polymerase gamma | 2 | 2 | ||||||||
MIRT452856 | LAX1 | lymphocyte transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT453048 | TANGO2 | transport and golgi organization 2 homolog | 2 | 2 | ||||||||
MIRT459389 | MPLKIP | M-phase specific PLK1 interacting protein | 2 | 2 | ||||||||
MIRT461156 | SLC11A2 | solute carrier family 11 member 2 | 2 | 4 | ||||||||
MIRT461613 | PTCD3 | pentatricopeptide repeat domain 3 | 2 | 2 | ||||||||
MIRT463711 | YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 2 | 8 | ||||||||
MIRT464107 | VPS35 | VPS35, retromer complex component | 2 | 2 | ||||||||
MIRT466438 | TFAM | transcription factor A, mitochondrial | 2 | 2 | ||||||||
MIRT467735 | SLC36A1 | solute carrier family 36 member 1 | 2 | 2 | ||||||||
MIRT469512 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 6 | ||||||||
MIRT470026 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 2 | ||||||||
MIRT473411 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT480545 | BZW1 | basic leucine zipper and W2 domains 1 | 2 | 2 | ||||||||
MIRT488444 | ACBD3 | acyl-CoA binding domain containing 3 | 2 | 2 | ||||||||
MIRT489498 | CRLF3 | cytokine receptor like factor 3 | 2 | 4 | ||||||||
MIRT496149 | RPS15A | ribosomal protein S15a | 2 | 2 | ||||||||
MIRT497013 | PRDM2 | PR/SET domain 2 | 2 | 2 | ||||||||
MIRT497087 | PHF12 | PHD finger protein 12 | 2 | 2 | ||||||||
MIRT508695 | MTRNR2L4 | MT-RNR2-like 4 | 2 | 4 | ||||||||
MIRT517468 | PEX26 | peroxisomal biogenesis factor 26 | 2 | 2 | ||||||||
MIRT525329 | CNGB1 | cyclic nucleotide gated channel beta 1 | 2 | 2 | ||||||||
MIRT527842 | RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 2 | 2 | ||||||||
MIRT529111 | AQPEP | laeverin | 1 | 1 | ||||||||
MIRT530163 | C11orf44 | chromosome 11 open reading frame 44 | 2 | 4 | ||||||||
MIRT532249 | TBPL2 | TATA-box binding protein like 2 | 2 | 2 | ||||||||
MIRT532828 | ZNF704 | zinc finger protein 704 | 2 | 2 | ||||||||
MIRT533140 | WNT10A | Wnt family member 10A | 2 | 2 | ||||||||
MIRT536481 | KIAA1468 | KIAA1468 | 2 | 2 | ||||||||
MIRT536802 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 2 | 2 | ||||||||
MIRT537301 | FRS2 | fibroblast growth factor receptor substrate 2 | 2 | 2 | ||||||||
MIRT542650 | TAF1D | TATA-box binding protein associated factor, RNA polymerase I subunit D | 2 | 2 | ||||||||
MIRT545691 | NUTF2 | nuclear transport factor 2 | 2 | 2 | ||||||||
MIRT546960 | PRR14L | proline rich 14 like | 2 | 2 | ||||||||
MIRT560566 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT561792 | PAWR | pro-apoptotic WT1 regulator | 2 | 2 | ||||||||
MIRT562372 | ERI2 | ERI1 exoribonuclease family member 2 | 2 | 2 | ||||||||
MIRT569292 | SURF6 | surfeit 6 | 2 | 2 | ||||||||
MIRT574090 | VASN | vasorin | 2 | 2 | ||||||||
MIRT619787 | HLCS | holocarboxylase synthetase | 2 | 2 | ||||||||
MIRT620104 | HARBI1 | harbinger transposase derived 1 | 2 | 2 | ||||||||
MIRT626003 | ZNF517 | zinc finger protein 517 | 2 | 2 | ||||||||
MIRT626375 | BBS1 | Bardet-Biedl syndrome 1 | 2 | 2 | ||||||||
MIRT626615 | SLC30A6 | solute carrier family 30 member 6 | 2 | 2 | ||||||||
MIRT628381 | CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 | 2 | 2 | ||||||||
MIRT629299 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | 1 | 1 | ||||||||
MIRT630439 | IDE | insulin degrading enzyme | 2 | 2 | ||||||||
MIRT631848 | PIGG | phosphatidylinositol glycan anchor biosynthesis class G | 2 | 2 | ||||||||
MIRT633171 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT633472 | ZNF724P | zinc finger protein 724 | 2 | 2 | ||||||||
MIRT634389 | PLSCR1 | phospholipid scramblase 1 | 2 | 2 | ||||||||
MIRT635536 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT635818 | OPA3 | OPA3, outer mitochondrial membrane lipid metabolism regulator | 2 | 2 | ||||||||
MIRT636165 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT636792 | CYB5D1 | cytochrome b5 domain containing 1 | 2 | 2 | ||||||||
MIRT637946 | IVD | isovaleryl-CoA dehydrogenase | 2 | 2 | ||||||||
MIRT640317 | STAT1 | signal transducer and activator of transcription 1 | 2 | 2 | ||||||||
MIRT645131 | HES2 | hes family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT645658 | ADK | adenosine kinase | 2 | 2 | ||||||||
MIRT646143 | FLVCR1 | feline leukemia virus subgroup C cellular receptor 1 | 2 | 2 | ||||||||
MIRT646999 | NCR3LG1 | natural killer cell cytotoxicity receptor 3 ligand 1 | 2 | 2 | ||||||||
MIRT648183 | C2orf68 | chromosome 2 open reading frame 68 | 2 | 2 | ||||||||
MIRT650085 | TERF2 | telomeric repeat binding factor 2 | 2 | 2 | ||||||||
MIRT650326 | RTN2 | reticulon 2 | 2 | 2 | ||||||||
MIRT651562 | WHSC1L1 | nuclear receptor binding SET domain protein 3 | 2 | 2 | ||||||||
MIRT659367 | CREG2 | cellular repressor of E1A stimulated genes 2 | 2 | 2 | ||||||||
MIRT659830 | CARHSP1 | calcium regulated heat stable protein 1 | 2 | 2 | ||||||||
MIRT662103 | LACTB | lactamase beta | 2 | 4 | ||||||||
MIRT664837 | HUS1 | HUS1 checkpoint clamp component | 2 | 2 | ||||||||
MIRT669750 | ZNF101 | zinc finger protein 101 | 2 | 4 | ||||||||
MIRT669791 | GAN | gigaxonin | 2 | 2 | ||||||||
MIRT670044 | RPP14 | ribonuclease P/MRP subunit p14 | 2 | 2 | ||||||||
MIRT670293 | RBBP4 | RB binding protein 4, chromatin remodeling factor | 2 | 2 | ||||||||
MIRT670382 | EMP2 | epithelial membrane protein 2 | 2 | 2 | ||||||||
MIRT670950 | UGGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | 2 | 4 | ||||||||
MIRT672854 | C22orf29 | retrotransposon Gag like 10 | 2 | 2 | ||||||||
MIRT672885 | FXN | frataxin | 2 | 2 | ||||||||
MIRT673994 | KCNN3 | potassium calcium-activated channel subfamily N member 3 | 2 | 2 | ||||||||
MIRT674155 | BLOC1S3 | biogenesis of lysosomal organelles complex 1 subunit 3 | 2 | 2 | ||||||||
MIRT674495 | TIRAP | TIR domain containing adaptor protein | 2 | 2 | ||||||||
MIRT675461 | NUBPL | nucleotide binding protein like | 2 | 2 | ||||||||
MIRT675669 | TMOD2 | tropomodulin 2 | 2 | 2 | ||||||||
MIRT675994 | CRKL | CRK like proto-oncogene, adaptor protein | 2 | 2 | ||||||||
MIRT676069 | TIMM50 | translocase of inner mitochondrial membrane 50 | 2 | 2 | ||||||||
MIRT676378 | SEC24D | SEC24 homolog D, COPII coat complex component | 2 | 2 | ||||||||
MIRT676759 | SNX2 | sorting nexin 2 | 2 | 2 | ||||||||
MIRT676893 | GABPB1 | GA binding protein transcription factor beta subunit 1 | 2 | 2 | ||||||||
MIRT676973 | ZNF708 | zinc finger protein 708 | 2 | 2 | ||||||||
MIRT677229 | C15orf40 | chromosome 15 open reading frame 40 | 2 | 2 | ||||||||
MIRT677363 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | 2 | 2 | ||||||||
MIRT677456 | PDLIM3 | PDZ and LIM domain 3 | 2 | 2 | ||||||||
MIRT678073 | EIF2A | eukaryotic translation initiation factor 2A | 2 | 2 | ||||||||
MIRT678091 | ATCAY | ATCAY, caytaxin | 2 | 2 | ||||||||
MIRT678316 | FBLIM1 | filamin binding LIM protein 1 | 2 | 2 | ||||||||
MIRT678411 | ANKRD36 | ankyrin repeat domain 36 | 2 | 2 | ||||||||
MIRT678519 | ZNF347 | zinc finger protein 347 | 2 | 2 | ||||||||
MIRT678695 | TRIP11 | thyroid hormone receptor interactor 11 | 2 | 2 | ||||||||
MIRT678821 | PDE6A | phosphodiesterase 6A | 2 | 2 | ||||||||
MIRT679984 | RUNDC1 | RUN domain containing 1 | 2 | 2 | ||||||||
MIRT680608 | KIAA0391 | KIAA0391 | 2 | 2 | ||||||||
MIRT680724 | PRICKLE1 | prickle planar cell polarity protein 1 | 2 | 2 | ||||||||
MIRT681238 | ZNF383 | zinc finger protein 383 | 2 | 2 | ||||||||
MIRT681932 | SLC19A3 | solute carrier family 19 member 3 | 2 | 2 | ||||||||
MIRT682003 | ATP5S | ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B) | 2 | 2 | ||||||||
MIRT682500 | HERPUD1 | homocysteine inducible ER protein with ubiquitin like domain 1 | 2 | 2 | ||||||||
MIRT685460 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT688193 | FNIP1 | folliculin interacting protein 1 | 2 | 2 | ||||||||
MIRT689666 | RBM23 | RNA binding motif protein 23 | 2 | 2 | ||||||||
MIRT691058 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT691442 | CXorf36 | chromosome X open reading frame 36 | 2 | 2 | ||||||||
MIRT695998 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | 2 | 2 | ||||||||
MIRT696395 | CORO7 | coronin 7 | 2 | 2 | ||||||||
MIRT702334 | KLHL7 | kelch like family member 7 | 2 | 2 | ||||||||
MIRT702555 | KBTBD6 | kelch repeat and BTB domain containing 6 | 2 | 2 | ||||||||
MIRT703362 | GAPVD1 | GTPase activating protein and VPS9 domains 1 | 2 | 2 | ||||||||
MIRT703551 | FKBP14 | FK506 binding protein 14 | 2 | 2 | ||||||||
MIRT705029 | CACUL1 | CDK2 associated cullin domain 1 | 2 | 2 | ||||||||
MIRT706335 | STAC2 | SH3 and cysteine rich domain 2 | 2 | 2 | ||||||||
MIRT708907 | TM4SF19 | transmembrane 4 L six family member 19 | 2 | 2 | ||||||||
MIRT711625 | CORO1C | coronin 1C | 2 | 2 | ||||||||
MIRT714444 | TOPAZ1 | testis and ovary specific PAZ domain containing 1 | 2 | 2 | ||||||||
MIRT716324 | POU5F1 | POU class 5 homeobox 1 | 2 | 2 | ||||||||
MIRT718568 | SLC25A22 | solute carrier family 25 member 22 | 2 | 2 | ||||||||
MIRT720299 | DDHD1 | DDHD domain containing 1 | 2 | 2 | ||||||||
MIRT721449 | AGPAT6 | glycerol-3-phosphate acyltransferase 4 | 2 | 2 | ||||||||
MIRT723529 | NFATC2IP | nuclear factor of activated T-cells 2 interacting protein | 2 | 2 | ||||||||
MIRT724492 | BFAR | bifunctional apoptosis regulator | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|